Abstract:Many non-coding RNAs (ncRNAs) serve as regulatory molecules in various physiological pathways, including gene expression in mammalian cells. Distinct from protein-coding RNA expression, ncRNA expression is regulated solely by transcription and RNA processing/stability. It is thus important to understand transcriptional regulation in ncRNA genes but is yet to be known completely. Previously, we identified that a subset of mammalian ncRNA genes is transcriptionally regulated by RNA polymerase II (Pol II) promoter-proximal pausing and in a tissue-specific manner. In this study, human ncRNA genes that are expressed in the early G1 phase, termed immediate early ncRNA genes, were monitored to assess the function of positive transcription elongation factor b (P-TEFb), a master Pol II pausing regulator for protein-coding genes, in ncRNA transcription. Our findings indicate that the expression of many ncRNA genes is induced in the G0-G1 transition and regulated by P-TEFb. Interestingly, a biphasic characteristic of P-TEFb-dependent transcription of serum responsive ncRNA genes was observed: Pol II carboxyl-terminal domain phosphorylated at serine 2 (S2) was largely increased in the transcription start site (TSS, -300 to +300) whereas overall, it was decreased in the gene body (GB, > +350) upon chemical inhibition of P-TEFb. In addition, the three representative, immediate early ncRNAs, whose expression is dependent on P-TEFb, metastasis-associated lung adenocarcinoma transcript 1 (MALAT1), nuclear enriched abundant transcript 1 (NEAT1), and X-inactive specific transcript (XIST), were further analyzed for determining P-TEFb association. Taken together, our data suggest that transcriptional activation of many human ncRNAs utilizes the pausing and releasing of Pol II, and that the regulatory mechanism of transcriptional elongation in these genes requires the function of P-TEFb. Furthermore, we propose that ncRNA and mRNA transcription are regulated by similar mechanisms while P-TEFb inhibition unexpectedly increases S2 Pol II phosphorylation in the TSSs in many ncRNA genes. One Sentence Summary: P-TEFb regulates Pol II phosphorylation for transcriptional activation in many stimulus-inducible ncRNA genes.

RNA Polymerase II–associated Factor 1 Regulates the Release and Phosphorylation of Paused RNA Polymerase II

PAF1, a Molecular Regulator of Promoter-Proximal Pausing by RNA Polymerase II

Paf1 Regulation Of Promoter-Proximal Pause Release Via Enhancer Activation

Coordinated regulation of RNA polymerase II pausing and elongation progression by PAF1

Paf1C regulates RNA polymerase II progression by modulating elongation rate

PAF1C allosterically activates CDK12/13 kinase during RNAPII transcript elongation

Transcriptional Regulation of Pp2a-A Alpha is Mediated by Multiple Factors Including Ap-2 Alpha, Creb, Ets-1, and Sp-1

Distinct Cdk9-phosphatase switches act at the beginning and end of elongation by RNA polymerase II

Pause Patrol: Negative Elongation Factor's role in Promoter-Proximal Pausing and beyond

Coordinate control of the RNA polymerase II transcription cycle by CDK9-dependent, tripartite phosphorylation of SPT5

Distinct negative elongation factor conformations regulate RNA polymerase II promoter-proximal pausing

RNA polymerase II elongation factors use conserved regulatory mechanisms

P-TEFb Regulates Transcriptional Activation in Non-coding RNA Genes

CDK9 keeps RNA polymerase II on track

Phase-separation mechanism for C-terminal hyperphosphorylation of RNA polymerase II

SR Proteins Collaborate with 7SK and Promoter-Associated Nascent RNA to Release Paused Polymerase

The Phosphatase PP1 Sustains Global Transcription by Promoting RNA Polymerase II Pause Release

Promoter-proximal pausing of RNA polymerase II: a nexus of gene regulation

The CDK9-SPT5 axis in control of transcription elongation by RNAPII

Getting up to speed with transcription elongation by RNA polymerase II

CDK12 and Integrator-PP2A complex modulates LEO1 phosphorylation for processive transcription elongation